Tag Archives: Central Nervous System (CNS) Biomarkers Market

The use of biomarkers for the diagnosis and monitoring of a wide range of neurological illnesses has given rise to a burgeoning market for CNS biomarkers. Cerebrospinal fluid (CSF), blood, and urine biomarkers can aid in the early detection and diagnosis of neurological diseases like Alzheimer’s, Parkinson’s, and MS. From 2023 to 2031, the market for biomarkers of central nervous ...